Chinese maker of low-cost quadrupeds and the G1/H1/R1 humanoids; filing to IPO.
In a Nature-published preclinical trial, teleoperated Unitree G1 humanoids removed gallbladders from live pigs — a world first for humanoid robots in surgery, using standard surgical tools under full human control, with recalibration and latency still limiting.
China's securities regulator cleared Unitree's registration for a ~¥4.2B ($618M) STAR Market IPO — at least 40.4M shares (~10%), implying a ~$6.2B valuation, with a debut possible as early as late July.
Alibaba-affiliate Ant Group led a 500M yuan (~$74M) round in robotics firm Zeroth — its 12th humanoid-sector deal since early 2025, a portfolio spanning Unitree, Galaxea and parts/software startups, plus its own RobbyAnt subsidiary.
Neubility signed a strategic-partnership MOU with Unitree to co-develop industrial robot solutions, pairing Neubility's autonomous-navigation platform with Unitree's robot hardware.
GMO started selling Unitree humanoid robots in Japan — a new commercial channel.
No coverage matches this filter yet.